Health Care & Life Sciences » Pharmaceuticals | Enzon Pharmaceuticals Inc.

Enzon Pharmaceuticals Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
6,520.00
34,562.00
11,672.00
7,639.00
7,478.00
6,500
Other Current Assets
601.00
478.00
107.00
270.00
94.00
70
Total Current Assets
7,121.00
35,040.00
11,779.00
7,909.00
7,572.00
14,540
Other Assets
-
-
-
-
1,940.00
970
Total Assets
7,121.00
35,040.00
22,890.00
11,271.00
9,512.00
15,510
Accounts Payable
93.00
181.00
90.00
770.00
225.00
Other Current Liabilities
1,215.00
4,875.00
4,711.00
170.00
143.00
Total Current Liabilities
1,308.00
5,056.00
4,801.00
940.00
368.00
Deferred Taxes
-
-
11,111.00
3,362.00
-
Other Liabilities
558.00
381.00
-
-
-
Total Liabilities
1,866.00
5,437.00
4,801.00
940.00
368.00
Common Equity (Total)
5,255.00
29,603.00
18,089.00
10,331.00
9,144.00
Total Shareholders' Equity
5,255.00
29,603.00
18,089.00
10,331.00
9,144.00
Total Equity
5,255.00
29,603.00
18,089.00
10,331.00
9,144.00
Liabilities & Shareholders' Equity
7,121.00
35,040.00
22,890.00
11,271.00
9,512.00

About Enzon Pharmaceuticals

View Profile
Address
20 Commerce Drive
Cranford New Jersey 07016
United States
Employees -
Website http://www.enzon.com
Updated 07/08/2019
Enzon Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the provision of licensing arrangements related to sales of drug products that utilize its proprietary technology. The company was founded on September 17, 1981 and is headquartered in Cranford, NJ. .

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.